<乌鸦传媒>Fate of Transcatheter Tricuspid Devices: Will it Be Repair or Replacement? Many unanswered questions remain regarding devices for tricuspid regurgitation Jun 11, 2022
<乌鸦传媒>TAVR Devices Keep Changing -- Is This Really Helping Patients? Clinical outcomes are headed in the right direction, but better research is needed Jun 10, 2022
<乌鸦传媒>Good News for Heart Failure Patients Getting COVID Booster Shots Group saw lower risks for hospitalization, ICU admission, death versus the unvaccinated Jun 09, 2022
<乌鸦传媒>Promising First Dips Into a Bigger Pool of MitraClip Candidates Real-world outcomes in people with secondary MR who don't fit COAPT criteria Jun 09, 2022
<乌鸦传媒>SGLT2 Inhibitors a Better First Drug in Type 2 Diabetes Than Metformin? Observational study suggests some cardiovascular benefit May 23, 2022
<乌鸦传媒>TAVR for Aortic Regurgitation Off to a Good Start in the Real World Yet some growing pains remain for the Jenavalve Trilogy May 21, 2022
<乌鸦传媒>No-Implant Shunt Eases HF Symptoms in Early Data Quality of life consistently improved across first-in-man studies May 20, 2022
<乌鸦传媒>Device Type Matters for Valve-in-Valve TAVR in Small Anatomies Showdown between Sapien and Evolut valves in the LYTEN trial May 20, 2022
<乌鸦传媒>Harmony Pulmonary Valves 'Behaving' at 1 Year Pooled study data show no mortality, favorable clinical outcomes May 20, 2022
<乌鸦传媒>TAVR Stays Its Course as 10-Year Durability Data Trickle In Glimpse of longer-term valve degeneration in early TAVR patients May 19, 2022
<乌鸦传媒>Do Pediatric Electrophysiologists Have It Harder? Clinicians discuss the dilemmas and shortcomings in the field May 02, 2022
<乌鸦传媒>Cardiac Myosin Inhibitor Gets FDA's Blessing for Obstructive HCM First-in-class mavacamten will be subject to REMS, however Apr 29, 2022
<乌鸦传媒>In These Patients, NT-proBNP Underestimates Heart Failure Risk Is it time for sex- and race-specific risk thresholds? Apr 27, 2022
<乌鸦传媒>Even With CKD, Patiromer Helped Heart Failure Patients Keep Hyperkalemia at Bay Promising findings from prespecified renal analysis of the DIAMOND trial Apr 09, 2022
<乌鸦传媒>Systemic Corticosteroids in Acute HF: Worth Another Look? Some see a potential treatment for patients with more inflammation Apr 08, 2022
<乌鸦传媒>Stroke While on LVAD No Barrier to Successful Heart Transplant It doesn't help, for sure, but it doesn't seem to hurt greatly either Apr 05, 2022
<乌鸦传媒>TAVR Valve Outlasts Surgical Bioprostheses at 5 Years No longer assume that TAVR bioprostheses are inherently less durable Apr 05, 2022
<乌鸦传媒>Patiromer Limits Impact of RAAS Inhibitor-Related Hyperkalemia in HF Patients better able to achieve target dose of mineralocorticoids and angiotensin inhibitors Apr 04, 2022
<乌鸦传媒>Transcatheter Tricuspid Repair Shows Early Promise PASCAL device safe and linked to symptom improvement in severe tricuspid regurgitation Apr 04, 2022
<乌鸦传媒>Flu Vaccine Didn't Stop Vascular Events in Heart Failure Patients But study in lower income countries sees hint of benefit during peak disease season Apr 04, 2022
<乌鸦传媒>EHR Pop-Ups Spur Better GDMT Implementation in Heart Failure Alert-based intervention in PROMPT-HF trial said to be low-cost, scalable Apr 03, 2022
<乌鸦传媒>Add-On Mavacamten Cuts Need for Septal Reduction in Obstructive HCM VALOR-HCM trial shows novel cardiac myosin inhibitor beneficial as targeted treatment Apr 02, 2022
<乌鸦传媒>Low-Salt Diet Helpful for HF Symptoms, but Not Necessarily for Clinical Events Sodium restriction still holds its ground in SODIUM-HF trial Apr 02, 2022
<乌鸦传媒>From 'Pre-HF' to 'HFimpEF': Guidelines Redefine Heart Failure Stages, Classes Update also adds SGLT2 inhibitor as a pillar of therapy Apr 01, 2022
<乌鸦传媒>In-Person ACC Meeting Returns, Serving Diet Intervention Studies and More Will salt restriction finally get a boost at this weekend's meeting? Mar 31, 2022
<乌鸦传媒>Obstructive HCM: Will Septal Reduction Zapping Hold Up? More progress on PIMSRA at one Chinese center Mar 30, 2022
<乌鸦传媒>Cranberry's Vascular Effects; Cardioprotective Penile Vibrations; EHR Score for CAD Recent developments of interest in cardiovascular medicine Mar 22, 2022
<乌鸦传媒>In HFpEF, Do MRA Users Get as Much Benefit From an SGLT2 Inhibitor? EMPEROR-Preserved trial weighs in Mar 21, 2022
<乌鸦传媒>Ross Procedure Best for Fixing Aortic Valve in Younger Patients? Propensity-matched analysis may suggest it's time for "Ross Centers of Excellence" Mar 07, 2022
<乌鸦传媒>ARB-Cancer Link May Come Down to Cumulative Exposure Does a new paper resolve the conflicting safety data on the popular antihypertensives? Mar 02, 2022
<乌鸦传媒>AirPods-Pacemaker Risk; Not Enough Valve Interventions; Baby-Shaking Cardiologist Recent developments of interest in cardiovascular medicine Mar 01, 2022
<乌鸦传媒>Salt in Fizzy Tablets Linked to Heart, Death Risk Warning signals seen for fast-acting acetaminophen and other drugs Feb 24, 2022
<乌鸦传媒>A Simple Way to Tell When Asymptomatic Aortic Stenosis Isn't So Benign Could regular NT-proBNP testing be of value to patients with non-severe AS? Feb 16, 2022
<乌鸦传媒>ACIP Embraces Spikevax Amid Serious Talk of Changing mRNA Dosing Interval Would longer time between doses do the trick to reduce myocarditis risk? Feb 04, 2022
<乌鸦传媒>Gestational Diabetes Tied to Long-Term Cardiovascular Risks Chronic comorbidities partly explain risk, researcher says Feb 04, 2022
<乌鸦传媒>Adult Congenital Heart Surgery: Go for the Pediatric Specialists? Study suggests worse outcomes at adult centers with expertise in other heart surgeries Jan 31, 2022
<乌鸦传媒>Donor Hearts Can Withstand Longer Ischemic Times Over 4 hours not inherently more dangerous, one group finds Jan 31, 2022
<乌鸦传媒>Was DOAC to Blame for Patient's LVAD Pump Thrombosis? Direct oral anticoagulant tried after warfarin resistance fell short in this patient with obesity Jan 21, 2022
<乌鸦传媒>Signs of Lingering Cardiac Dysfunction After Severe COVID Study included people hospitalized before vaccines were available Jan 20, 2022
<乌鸦传媒>Caution: Paxlovid Interacts With Many Heart Meds The Skeptical Cardiologist asks clinicians and patients to take note Jan 17, 2022
